Researchers identify new class of antifungal agents

23 junio 2015

A new class of antifungals has been identified, potentially useful to treat the more than 300 million people worldwide who develop serious fungal infections. Fungal infections are most commonly found in individuals with medical conditions that compromise the immune system, such as AIDS, or individuals who are being treated with immunosuppressives, such as those battling cancer. The three classes of antifungal drugs currently available–azoles, polyenes, and echinocandins–are far from optimal.